{"id":"NCT04530838","sponsor":"Pfizer","briefTitle":"20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Healthy Japanese Infants","officialTitle":"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, THIRD PARTY UNBLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY JAPANESE INFANTS","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-09-16","primaryCompletion":"2022-04-02","completion":"2022-04-02","firstPosted":"2020-08-28","resultsPosted":"2023-04-21","lastUpdate":"2023-04-21"},"enrollment":668,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Pneumococcal Disease"],"interventions":[{"type":"BIOLOGICAL","name":"20-valent pneumococcal conjugate vaccine","otherNames":[]},{"type":"BIOLOGICAL","name":"13-valent pneumococcal conjugate vaccine","otherNames":[]}],"arms":[{"label":"20-valent pneumococcal conjugate vaccine (subcutaneous)","type":"EXPERIMENTAL"},{"label":"13-valent pneumococcal conjugate vaccine (subcutaneous)","type":"ACTIVE_COMPARATOR"},{"label":"20-valent pneumococcal conjugate vaccine (intramuscular)","type":"EXPERIMENTAL"}],"summary":"20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Healthy Japanese Infants","primaryOutcome":{"measure":"Percentage of Participants With Local Reactions (LR) Within 7 Days After Dose 1","timeFrame":"Within 7 Days after Dose 1","effectByArm":[{"arm":"20vPnC (SC)","deltaMin":58.2,"sd":51.5},{"arm":"13vPnC (SC)","deltaMin":51.3,"sd":44.6},{"arm":"20vPnC (IM)","deltaMin":26.3,"sd":20.5}],"pValues":[]},"eligibility":{"minAge":"2 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":2,"exclusionCount":4},"locations":{"siteCount":38,"countries":["Japan"]},"refs":{"pmids":["38242195"],"seeAlso":["https://pmiform.com/clinical-trial-info-request?StudyID=B7471016"]},"adverseEventsSummary":{"seriousAny":{"events":14,"n":225},"commonTop":["Injection site erythema (REDNESS)","Injection site swelling (SWELLING)","Hypersomnia (INCREASED SLEEP)","Pyrexia (FEVER)","Irritability (IRRITABILITY)"]}}